Trademarkia Logo

Australia

AU$
DAXXIFY
Registered: Registered/protected

Last updated on 30 May 2025

Owner Info

Revance Therapeutics, Inc. a Delaware Corporation

7555 Gateway Boulevard

Newark, CA, 94560 UNITED STATES OF AMERICA,

Serial Number

2123384 filed on 25 Sept 2020

Correspondent

IP SOLVED (ANZ) PTY. LTD.

PO BOX R1791,

ROYAL EXCHANGE, NSW, 1225 AUSTRALIA,

DAXXIFY

Classification Information


Class [005]
pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headach Read More

Mark Details


Serial Number

2123384

Registered On

25 Sept 2020

Renewal On

25 Sept 2030

Mark Type

WORD

Priority Claim (Convention Details)


Date

30 Mar 2020

Mark Type

US

Legal History


Show more

Status DateAction Taken
30th May 2025Customer Amendment Made correspondence sent
30th May 2025Customer Amendment Made correspondence sent
23rd May 2025Amendment to Address for Service Requested
11th Jan 2021IP Right Registered correspondence sent
11th Jan 2021IP Right Registration Published
11th Jan 2021Status change to Registered/Protected
28th Oct 2020Application Accepted correspondence sent
27th Oct 2020IP Right has been Examined
27th Oct 2020IP Right Acceptance Published
27th Oct 2020Status change to Accepted